AntibioTx is a privately held, clinical stage, pharmaceutical company dedicated to the development of a novel class of antibiotics with a new mechanism of action to treat bacterial infections and related disorders that are currently causing harm to millions of patients worldwide. AntibioTx has a fully operational lab and has utilized cutting edge systems biology and screening methods to identify and characterize a potential game changing class of antibiotics.


Attracting, building and retaining expertise to be a sustainable innovator of treatment options at the intercept of microbiology and immunology.


Learn more